CN104013972B - A kind of preparation method of hydrophilic belulinic acid Betulinic acid preparation - Google Patents

A kind of preparation method of hydrophilic belulinic acid Betulinic acid preparation Download PDF

Info

Publication number
CN104013972B
CN104013972B CN201410289470.4A CN201410289470A CN104013972B CN 104013972 B CN104013972 B CN 104013972B CN 201410289470 A CN201410289470 A CN 201410289470A CN 104013972 B CN104013972 B CN 104013972B
Authority
CN
China
Prior art keywords
preparation
acid
belulinic
beta
betulinic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410289470.4A
Other languages
Chinese (zh)
Other versions
CN104013972A (en
Inventor
王霆
董仕辉
阎秀峰
王洋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeast Forestry University
Original Assignee
Northeast Forestry University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeast Forestry University filed Critical Northeast Forestry University
Priority to CN201410289470.4A priority Critical patent/CN104013972B/en
Publication of CN104013972A publication Critical patent/CN104013972A/en
Application granted granted Critical
Publication of CN104013972B publication Critical patent/CN104013972B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The preparation method of a kind of hydrophilic belulinic acid Betulinic acid preparation, relates to the preparation method of a kind of belulinic acid Betulinic acid preparation.The present invention is to solve that belulinic acid Betulinic acid is insoluble in water, and the problem limiting its application in terms of pharmaceutical preparation.Method: one, 6 tolysulfonyl beta cyclodextrin;Two, 6 diethylenetriamine chain beta cyclodextrin;Three, diethylenetriamine bridging beta cyclodextrin dimer;Four, 6 diethylenetriamine chain beta cyclodextrins or diethylenetriamine bridging beta cyclodextrin dimer are weighed in sample cell, add distilled water to dissolve, add belulinic acid Betulinic acid, after sonic oscillation, continue vibration on the oscillator, centrifugal, take supernatant aqueous phase cellulose filter membrane to filter, again filtrate is dried, obtains white powder, be hydrophilic belulinic acid Betulinic acid preparation.The present invention can be effectively improved belulinic acid Betulinic acid dissolubility in water, thus solves a belulinic acid Betulinic acid difficult problem in terms of biological preparation.The present invention is used for preparing belulinic acid Betulinic acid preparation.

Description

A kind of preparation method of hydrophilic belulinic acid Betulinic acid preparation
Technical field
The present invention relates to the preparation method of a kind of belulinic acid Betulinic acid preparation.
Background technology
Belulinic acid Betulinic acid (betulinicacid), has another name called betulic acid, is the compound of a kind of pentacyclic triterpene, is widely present in birch In bark and other plant, it is possible to prepared by betulinol synthesis, molecular weight 456.71g/mol, colorless needle crystals, molecule Formula: C30H48O3, molecular structural formula:
Belulinic acid Betulinic acid, as natural bioactive substance, has the effect such as malaria, antiinflammatory.Research finding, belulinic acid Betulinic acid is to people Class black cancer has good antitumaous effect, and the disease such as lymphatic cancer, carcinoma of prostate is also had good therapeutic effect.Birch Wood acid is because having the effect that antitumor increases, and there is also newly at anti-acquired immune deficiency syndrome (AIDS) (acquired immune deficiency syndrome (AIDS)) aspect Mechanism of action, caused the extensive concern of research worker.Belulinic acid Betulinic acid does not only have many medical mechanisms, but also Do not synthesize the toxicity of quasi drugs, the most do not synthesize the drug resistance of quasi drugs, so belulinic acid Betulinic acid has in terms of medicament research and development DEVELOPMENT PROSPECT widely.
But owing to belulinic acid Betulinic acid is insoluble in water, limit its application in terms of pharmaceutical preparation.
Cyclodextrin (Cyclodextrin is called for short CD) is a kind of cyclic oligomer sugar compounds, has particularly ring-shaped hollow circle Cylindrical structure, internal diameter 0.7~0.8nm can form clathrate with enclosed molecule (such as medicine) under certain condition.Conventional β-ring is stuck with paste Essence has the loop configuration being made up of 7 glucose molecules, appropriately processed with medicine after, pharmaceutical pack can be wrapped in its ring Shape structure is formed ultra micro capsule clathrate, the dissolubility of medicine, stability can be increased.But this dissolving in water of beta-schardinger dextrin- Degree is not very big, so the efficiency of inclusion medicine also ratio is relatively low.
Summary of the invention
The present invention is to solve that belulinic acid Betulinic acid is insoluble in water, and the problem limiting its application in terms of pharmaceutical preparation, it is provided that one Plant the preparation method of hydrophilic belulinic acid Betulinic acid preparation.
The preparation method of hydrophilic belulinic acid Betulinic acid preparation of the present invention, sequentially includes the following steps:
One, weigh 40~60g beta-schardinger dextrin-s to join in 400~500mL distilled water, obtain cyclodextrin solution, take 6~7g NaOH is dissolved in 20~25mL distilled water, obtains NaOH solution, and the NaOH solution of preparation is added dropwise to cyclodextrin In solution, obtain transparent and homogeneous solution, take 7~10g p-methyl benzene sulfonic chlorides and be dissolved in 30~40mL acetonitriles, must mix molten Liquid, is added dropwise to mixed solution in transparent and homogeneous solution, is stirred at room temperature reaction 2~4h, and sucking filtration is precipitated, Filtrate is preserved at 0~5 DEG C 12h, then sucking filtration must precipitate, the precipitation vacuum drying 12~16h that twice is obtained, obtain White solid, with absolute ethanol washing white solid 3~5 times, uses dehydrated alcohol 50~80mL every time, obtains 6-to toluene Sulphonyl-beta-schardinger dextrin-;
Two, weigh 1.5~3g6-tolysulfonyl-beta-schardinger dextrin-, 20~30mgKI and 0.5~1.0mL diethylenetriamine is molten In the 5~8mL N-Methyl pyrrolidone being dried, under the conditions of 70~80 DEG C, stirring reaction 4~7h, obtains yellow solution, Being cooled to room temperature, yellow solution is poured into precipitation white precipitate in 100~150mL dehydrated alcohol, collected by suction white is sunk Form sediment, wash with 100~150mL dehydrated alcohol and 50~80mL ether respectively, be vacuum dried to obtain 1.3~2.5g product A, Being dissolved with 8~12mL distilled water by product A, carry out eluting with hydrogen ion exchange resin post, eluant is followed successively by 400~500 The ammonia of mL distilled water, 400~500mL1mol/L, the eluent collecting ammonia part concentrates, is vacuum dried, and obtains product Thing B, is dissolved in 20~30mL distilled water by product B, and decompression, concentrate drying obtains 6-diethylenetriamine chain-beta-schardinger dextrin-;
Three, 2.6~3.9g6-tolysulfonyl-beta-schardinger dextrin-and 1.2~2.4g6-diethylenetriamine chains-beta-schardinger dextrin-are weighed, It is dissolved in 80~100mLN, in dinethylformamide, at N2Reaction stirring 2~3 under protection and 75~85 DEG C of condition of water bath heating My god, reaction solution being concentrated into 20~30mL, is then added in 300~400mL acetone produce precipitation, sucking filtration is also used Acetone cyclic washing precipitates 3~5 times, then precipitation is dissolved in 10~15mL distilled water and filters with aqueous phase cellulose filter membrane, Filtrate is dried to obtain diethylenetriamine bridging-beta-schardinger dextrin-dimer;
Four, clathrate is produced: weigh 6-diethylenetriamine chain-beta-schardinger dextrin-or the 0.7~1.0g divinyl three of 0.5~0.7g Amine bridging-beta-schardinger dextrin-dimer, in sample cell, adds 5~6mL distilled water and makes it dissolve, add 30~40mg Belulinic acid Betulinic acid, after sonic oscillation 20~60min, continues vibration 6~7 days on the oscillator, be placed on afterwards in high speed centrifuge with 10000~12000rpm are centrifuged 15~30min, take supernatant aqueous phase cellulose filter membrane and filter, then filtrate are dried, Obtain white powder, be hydrophilic belulinic acid Betulinic acid preparation.
Described in step 2, resin column specification is: 25 × 450mm, 724 weak-acid cation-exchange resins, and height filled by resin Degree is 250mm.
Beneficial effects of the present invention:
Cyclodextrin derivatization, the not only high degree of the cyclodextrin after derivatization are added dissolubility own by the present invention, but also The inclusion to medicine can be promoted.The cyclodextrin derivative utilizing synthesis carries out inclusion to belulinic acid Betulinic acid, it is possible to be effectively improved belulinic acid Betulinic acid Dissolubility in water, thus solve a belulinic acid Betulinic acid difficult problem in terms of biological preparation.
Accompanying drawing explanation
Fig. 1 is the hydrophilic of belulinic acid Betulinic acid, 6-diethylenetriamine chain-beta-schardinger dextrin-, the two physical mixture and embodiment 1 preparation The infrared spectrum of type belulinic acid Betulinic acid preparation;Fig. 2 is belulinic acid Betulinic acid, 6-diethylenetriamine chain-beta-schardinger dextrin-, the two physical mixture X-ray diffractogram with the hydrophilic belulinic acid Betulinic acid preparation of embodiment 1 preparation;Fig. 3 is belulinic acid Betulinic acid standard specimen mass spectrum;Fig. 4 Hydrophilic belulinic acid Betulinic acid preparation for embodiment 1 preparation takes off the mass spectrum of thing of contracting for fixed output quotas;Fig. 5 is belulinic acid Betulinic acid standard specimen UPLC figure; Fig. 6 is the UPLC figure that hydrophilic belulinic acid Betulinic acid preparation prepared by embodiment 1 takes off thing of contracting for fixed output quotas;Fig. 7 is belulinic acid Betulinic acid, divinyl Triamine bridging beta-schardinger dextrin-dimer, the two physical mixture and hydrophilic belulinic acid Betulinic acid preparation infrared of embodiment 2 preparation Spectrogram;Fig. 8 is that belulinic acid Betulinic acid, diethylenetriamine bridging beta-schardinger dextrin-dimer, the two physical mixture and embodiment 2 are made The X-ray diffractogram of standby hydrophilic belulinic acid Betulinic acid preparation;Fig. 9 is the de-bag of hydrophilic belulinic acid Betulinic acid preparation of embodiment 2 preparation The mass spectrum of product;Figure 10 is the UPLC figure that hydrophilic belulinic acid Betulinic acid preparation prepared by embodiment takes off thing of contracting for fixed output quotas.
Detailed description of the invention
Technical solution of the present invention is not limited to act detailed description of the invention set forth below, also includes appointing between each detailed description of the invention Meaning combination.
Detailed description of the invention one: the preparation method of present embodiment hydrophilic belulinic acid Betulinic acid preparation, sequentially includes the following steps:
One, weigh 40~60g beta-schardinger dextrin-s to join in 400~500mL distilled water, obtain cyclodextrin solution, take 6~7g NaOH is dissolved in 20~25mL distilled water, obtains NaOH solution, and the NaOH solution of preparation is added dropwise to cyclodextrin In solution, obtain transparent and homogeneous solution, take 7~10g p-methyl benzene sulfonic chlorides and be dissolved in 30~40mL acetonitriles, must mix molten Liquid, is added dropwise to mixed solution in transparent and homogeneous solution, is stirred at room temperature reaction 2~4h, and sucking filtration is precipitated, Filtrate is preserved at 0~5 DEG C 12h, then sucking filtration must precipitate, the precipitation vacuum drying 12~16h that twice is obtained, obtain White solid, with absolute ethanol washing white solid 3~5 times, uses dehydrated alcohol 50~80mL every time, obtains 6-to toluene Sulphonyl-beta-schardinger dextrin-;
Two, weigh 1.5~3g6-tolysulfonyl-beta-schardinger dextrin-, 20~30mgKI and 0.5~1.0mL diethylenetriamine is molten In the 5~8mL N-Methyl pyrrolidone being dried, under the conditions of 70~80 DEG C, stirring reaction 4~7h, obtains yellow solution, Being cooled to room temperature, yellow solution is poured into precipitation white precipitate in 100~150mL dehydrated alcohol, collected by suction white is sunk Form sediment, wash with 100~150mL dehydrated alcohol and 50~80mL ether respectively, be vacuum dried to obtain 1.3~2.5g product A, Being dissolved with 8~12mL distilled water by product A, carry out eluting with hydrogen ion exchange resin post, eluant is followed successively by 400~500 The ammonia of mL distilled water, 400~500mL1mol/L, the eluent collecting ammonia part concentrates, is vacuum dried, and obtains product Thing B, is dissolved in 20~30mL distilled water by product B, and decompression, concentrate drying obtains 6-diethylenetriamine chain-beta-schardinger dextrin-;
Three, 2.6~3.9g6-tolysulfonyl-beta-schardinger dextrin-and 1.2~2.4g6-diethylenetriamine chains-beta-schardinger dextrin-are weighed, It is dissolved in 80~100mLN, in dinethylformamide, at N2Reaction stirring 2~3 under protection and 75~85 DEG C of condition of water bath heating My god, reaction solution being concentrated into 20~30mL, is then added in 300~400mL acetone produce precipitation, sucking filtration is also used Acetone cyclic washing precipitates 3~5 times, then precipitation is dissolved in 10~15mL distilled water and filters with aqueous phase cellulose filter membrane, Filtrate is dried to obtain diethylenetriamine bridging-beta-schardinger dextrin-dimer;
Four, clathrate is produced: weigh 6-diethylenetriamine chain-beta-schardinger dextrin-or the 0.7~1.0g divinyl three of 0.5~0.7g Amine bridging-beta-schardinger dextrin-dimer, in sample cell, adds 5~6mL distilled water and makes it dissolve, add 30~40mg Belulinic acid Betulinic acid, after sonic oscillation 20~60min, continues vibration 6~7 days on the oscillator, be placed on afterwards in high speed centrifuge with 10000~12000rpm are centrifuged 15~30min, take supernatant aqueous phase cellulose filter membrane and filter, then filtrate are dried, Obtain white powder, be hydrophilic belulinic acid Betulinic acid preparation.
Detailed description of the invention two: present embodiment is unlike detailed description of the invention one: weigh 2g6-in step 2 to first Benzene sulfonyl-beta-schardinger dextrin-, 25mgKI and 0.57mL diethylenetriamine are dissolved in the N-Methyl pyrrolidone that 5mL is dried. Other is identical with detailed description of the invention one.
Detailed description of the invention three: present embodiment is unlike detailed description of the invention one or two: resin column described in step 2 Specification is: 25 × 450mm, 724 weak-acid cation-exchange resins, and resin packed height is 250mm.Other with tool Body embodiment one or two is identical.
Detailed description of the invention four: present embodiment is unlike one of detailed description of the invention one to three: weigh 2.6 in step 3 G6-tolysulfonyl-beta-schardinger dextrin-and 2.4g6-diethylenetriamine chain-beta-schardinger dextrin-, be dissolved in 80mLN, N-dimethyl methyl In amide.Other is identical with one of detailed description of the invention one to three.
Detailed description of the invention five: present embodiment is unlike one of detailed description of the invention one to four: weigh 0.6 in step 4 The 6-diethylenetriamine chain-beta-schardinger dextrin-of g or 0.8g diethylenetriamine bridging-beta-schardinger dextrin-dimer are in sample cell.Its It is identical with one of detailed description of the invention one to four.
Detailed description of the invention six: present embodiment is unlike one of detailed description of the invention one to five: add in step 4 35mg belulinic acid Betulinic acid.Other is identical with one of detailed description of the invention one to five.
Detailed description of the invention seven: present embodiment is unlike one of detailed description of the invention one to six: dry described in step 4 Dry employing freeze-drying, particularly as follows: be placed on filtrate in freezer dryer, at-50 DEG C of precoolings 6~8h, 30~200 24~36h it are vacuum dried under Pa.Other is identical with one of detailed description of the invention one to six.
Embodiment 1:
The preparation method of the present embodiment hydrophilic belulinic acid Betulinic acid preparation, sequentially includes the following steps:
One, weigh 60g beta-schardinger dextrin-to join in 500mL distilled water, obtain cyclodextrin solution, take 6.5gNaOH molten In 20mL distilled water, obtain NaOH solution, the NaOH solution of preparation is added dropwise in cyclodextrin solution, To transparent and homogeneous solution, take 10g p-methyl benzene sulfonic chloride and be dissolved in 30mL acetonitrile, obtain mixed solution, by mixed solution Being added dropwise in transparent and homogeneous solution, be stirred at room temperature reaction 2h, sucking filtration is precipitated, and filtrate is protected at 5 DEG C Deposit 12h, then sucking filtration must precipitate, the precipitation vacuum drying 12h that twice is obtained, obtain white solid, wash with dehydrated alcohol Wash white solid 4 times, use dehydrated alcohol 60mL every time, obtain 6.4g6-tolysulfonyl-beta-schardinger dextrin-;
Two, weigh 2g6-tolysulfonyl-beta-schardinger dextrin-, 25mgKI and 0.57mL diethylenetriamine is dissolved in 5mL and does In dry N-Methyl pyrrolidone, under the conditions of 70 DEG C, stirring reaction 4h, obtains yellow solution, is cooled to room temperature, will Yellow solution pours precipitation white precipitate, collected by suction white precipitate in 100mL dehydrated alcohol into, uses 100mL respectively Dehydrated alcohol and the washing of 50mL ether, be vacuum dried to obtain 1.7g product A, is dissolved by product A 10mL distilled water, Carrying out eluting with hydrogen ion exchange resin post, eluant is followed successively by the ammonia of 400mL distilled water, 500mL1mol/L, The eluent collecting ammonia part concentrates, is vacuum dried, and obtains product B, product B is dissolved in 20mL distilled water, subtracts Pressure, concentrate drying obtains 1.4g6-diethylenetriamine chain-beta-schardinger dextrin-;
Three, produce clathrate: weigh the 6-diethylenetriamine chain-beta-schardinger dextrin-of 0.5g in sample cell, add 5mL and steam Distilled water makes it dissolve, and adds 30mg belulinic acid Betulinic acid, after sonic oscillation 30min, continues vibration 7 days on the oscillator, It is centrifuged 15min with 10000rpm in being placed on high speed centrifuge afterwards, takes supernatant aqueous phase cellulose filter membrane and filter, then will Filtrate is dried, and obtains white powder, is hydrophilic belulinic acid Betulinic acid preparation.
It is dried described in step 3 and uses freeze-drying, particularly as follows: filtrate be placed in freezer dryer ,-50 DEG C of pre-coolings Freeze 6h, under 200Pa, be vacuum dried 24h.
Utilize infrared, mass spectrum, thermogravimetric analysis, X-ray diffraction and nuclear magnetic resonance, NMR to characterize, and utilize super effect liquid phase pair Clathrate takes off the solution after bag and carries out the detection of belulinic acid Betulinic acid content.Hydrophilic birch prepared by the present embodiment is recorded through super effect liquid phase In acid supplement, belulinic acid Betulinic acid content is 329.75 μ g/mL.
Fig. 1 be belulinic acid Betulinic acid, 6-diethylenetriamine chain-beta-schardinger dextrin-, the two physical mixture and the present embodiment prepare hydrophilic The infrared spectrum of type belulinic acid Betulinic acid preparation.In Fig. 1, a is belulinic acid Betulinic acid, and b is 6-diethylenetriamine chain-beta-schardinger dextrin-, and c is two Person's physical mixture, d is hydrophilic belulinic acid Betulinic acid preparation.Can be seen that belulinic acid Betulinic acid and 6-diethylenetriamine chain-beta-schardinger dextrin-are each Having the infrared signature absworption peak of self, the spectrogram of physical mixture has additivity, shows as the superposition of two components, and hydrophilic Type belulinic acid Betulinic acid preparation is different, the C=O stretching vibration absworption peak (1686.34cm of belulinic acid Betulinic acid association carboxylic acid-1) and C-O stretch Contracting vibration peak (1235.71cm-1) disappear, show that belulinic acid Betulinic acid, by inclusion, defines clathrate.
Fig. 2 be belulinic acid Betulinic acid, 6-diethylenetriamine chain-beta-schardinger dextrin-, the two physical mixture and the present embodiment prepare hydrophilic The X-ray diffractogram of type belulinic acid Betulinic acid preparation.In Fig. 2, a is belulinic acid Betulinic acid, and b is 6-diethylenetriamine chain-beta-schardinger dextrin-, c For the two physical mixture, d is hydrophilic belulinic acid Betulinic acid preparation.Belulinic acid Betulinic acid and 6-diethylenetriamine chain-beta-schardinger dextrin-each have Have visibly different diffraction maximum, in physical mixture spectrogram the diffraction maximum of existing belulinic acid Betulinic acid have again 6-diethylenetriamine chain-β- The diffraction maximum of cyclodextrin, and hydrophilic belulinic acid Betulinic acid preparation is different from physical mixture, the Partial Feature diffraction maximum of belulinic acid Betulinic acid disappears, Show really to define new thing phase, i.e. define clathrate.
Fig. 3 is belulinic acid Betulinic acid standard specimen mass spectrum, and Fig. 4 is the matter that hydrophilic belulinic acid Betulinic acid preparation prepared by the present embodiment takes off thing of contracting for fixed output quotas Spectrogram, it can be seen that in belulinic acid Betulinic acid standard substance figure, stable existence mass-to-charge ratio is the molecular ion peak of 454.8, at hydrophilic birch Acid supplement take off thing of contracting for fixed output quotas exists 455.0 molecular ion peak and intensity big, illustrate de-thing of contracting for fixed output quotas contains belulinic acid Betulinic acid.
Fig. 5 is belulinic acid Betulinic acid standard specimen UPLC figure, and Fig. 6 is that hydrophilic belulinic acid Betulinic acid preparation prepared by the present embodiment takes off thing of contracting for fixed output quotas UPLC schemes, and the de-belulinic acid Betulinic acid integrated peak areas contracted for fixed output quotas in thing is 74407, is brought into belulinic acid Betulinic acid standard curve linear equation A= In 6705.25C (μ g/mL)-14037.09 (correlation coefficient 0.9997), obtaining concentration is 13.19ppm, is computed Understand belulinic acid Betulinic acid dissolubility in water and increase to 329.75 μ g/mL.
Embodiment 2:
The preparation method of the present embodiment hydrophilic belulinic acid Betulinic acid preparation, sequentially includes the following steps:
One, weigh 50g beta-schardinger dextrin-to join in 500mL distilled water, obtain cyclodextrin solution, take 6gNaOH and be dissolved in In 20mL distilled water, obtain NaOH solution, the NaOH solution of preparation is added dropwise in cyclodextrin solution, obtains Transparent and homogeneous solution, takes 8g p-methyl benzene sulfonic chloride and is dissolved in 30mL acetonitrile, obtain mixed solution, by mixed solution dropwise Joining in transparent and homogeneous solution, be stirred at room temperature reaction 3h, sucking filtration is precipitated, and filtrate preserves at 5 DEG C 12h, Sucking filtration must precipitate again, the precipitation vacuum drying 14h obtained twice, obtains white solid, solid by absolute ethanol washing white Body 3 times, uses dehydrated alcohol 50mL every time, obtains 4.5g6-tolysulfonyl-beta-schardinger dextrin-;
Two, weigh 2g6-tolysulfonyl-beta-schardinger dextrin-, 30mgKI and 0.6mL diethylenetriamine is dissolved in 5mL and does In dry N-Methyl pyrrolidone, under the conditions of 75 DEG C, stirring reaction 7h, obtains yellow solution, is cooled to room temperature, will Yellow solution pours precipitation white precipitate, collected by suction white precipitate in 100mL dehydrated alcohol into, uses 100mL respectively Dehydrated alcohol and the washing of 50mL ether, be vacuum dried to obtain 1.7g product A, is dissolved by product A 10mL distilled water, Carrying out eluting with hydrogen ion exchange resin post, eluant is followed successively by the ammonia of 400mL distilled water, 400mL1mol/L, The eluent collecting ammonia part concentrates, is vacuum dried, and obtains product B, product B is dissolved in 20mL distilled water, subtracts Pressure, concentrate drying obtains 1.5g6-diethylenetriamine chain-beta-schardinger dextrin-;
Three, weigh 2.6g6-tolysulfonyl-beta-schardinger dextrin-and 2.4g6-diethylenetriamine chain-beta-schardinger dextrin-, be dissolved in 80mL In DMF, at N2Under protection and 80 DEG C of condition of water bath heating, reaction stirring 3 days, concentrate reaction solution To 20mL, being then added in 300mL acetone produce precipitation, sucking filtration also precipitates 5 times with acetone cyclic washing, then will Precipitation be dissolved in 15mL distilled water and with aqueous phase cellulose filter membrane filtration, filtrate be dried 3.8g diethylenetriamine bridging- Beta-schardinger dextrin-dimer;
Four, produce clathrate: weigh the diethylenetriamine bridging-beta-schardinger dextrin-dimer of 0.7g in sample cell, add 5 ML distilled water makes it dissolve, and adds 40mg belulinic acid Betulinic acid, after sonic oscillation 40min, continues vibration 7 on the oscillator My god, it is centrifuged 30min with 10000rpm in being placed on high speed centrifuge afterwards, takes supernatant aqueous phase cellulose filter membrane and filter, Again filtrate is dried, obtains white powder, be hydrophilic belulinic acid Betulinic acid preparation.
It is dried described in step 4 and uses freeze-drying, particularly as follows: filtrate be placed in freezer dryer ,-50 DEG C of pre-coolings Freeze 6h, under 200Pa, be vacuum dried 24h.
Utilize infrared, mass spectrum, thermogravimetric analysis, X-ray diffraction and nuclear magnetic resonance, NMR to characterize, and utilize super effect liquid phase pair Clathrate takes off the solution after bag and carries out the detection of belulinic acid Betulinic acid content.Hydrophilic birch prepared by the present embodiment is recorded through super effect liquid phase In acid supplement, belulinic acid Betulinic acid content is 336 μ g/mL.
Fig. 7 is prepared by belulinic acid Betulinic acid, diethylenetriamine bridging beta-schardinger dextrin-dimer, the two physical mixture and the present embodiment The infrared spectrum of hydrophilic belulinic acid Betulinic acid preparation.In Fig. 7, a is belulinic acid Betulinic acid, and b is diethylenetriamine bridging beta-schardinger dextrin-two Aggressiveness, c is the two physical mixture, and d is hydrophilic belulinic acid Betulinic acid preparation.The spectrogram that can be seen that physical mixture is birch Acid and the superposition of diethylenetriamine bridging beta-schardinger dextrin-dimer absworption peak, the C=O remaining belulinic acid Betulinic acid association carboxylic acid stretches Vibration absorption peak (1685.65cm-1) and C-O stretching vibration peak (1236.35cm-1), and hydrophilic belulinic acid Betulinic acid preparation spectrum Scheme significantly different, there is no the two characteristic absorption peak of belulinic acid Betulinic acid, show that belulinic acid Betulinic acid, by inclusion, defines clathrate.
Fig. 8 is prepared by belulinic acid Betulinic acid, diethylenetriamine bridging beta-schardinger dextrin-dimer, the two physical mixture and the present embodiment The X-ray diffractogram of hydrophilic belulinic acid Betulinic acid preparation.In Fig. 8, a is belulinic acid Betulinic acid, and b is that diethylenetriamine bridging β-ring is stuck with paste Essence dimer, c is the two physical mixture, and d is hydrophilic belulinic acid Betulinic acid preparation.As can be seen from the figure belulinic acid Betulinic acid and diethyl Alkene triamine bridging beta-schardinger dextrin-dimer each has visibly different diffraction maximum, and physical mixture spectrogram is the folded of two components Add, physical mixture remains the characteristic diffraction peak of belulinic acid Betulinic acid, and the feature diffraction of belulinic acid Betulinic acid in hydrophilic belulinic acid Betulinic acid preparation Peak disappears, and illustrates to define new thing phase, i.e. clathrate.
Fig. 9 is the mass spectrum that hydrophilic belulinic acid Betulinic acid preparation prepared by the present embodiment takes off thing of contracting for fixed output quotas, it can be seen that belulinic acid Betulinic acid standard In product figure, stable existence mass-to-charge ratio is the molecular ion peak of 454.8, exists in the de-thing of contracting for fixed output quotas of hydrophilic belulinic acid Betulinic acid preparation The molecular ion peak of 455.2 and intensity are big, illustrate in de-thing of contracting for fixed output quotas containing belulinic acid Betulinic acid.
Figure 10 is the UPLC figure that hydrophilic belulinic acid Betulinic acid preparation prepared by the present embodiment takes off thing of contracting for fixed output quotas, the de-birch in thing of contracting for fixed output quotas Acid integrated peak areas be 76094, be brought into belulinic acid Betulinic acid standard curve linear equation A=6705.25C (μ g/mL)- In 14037.09 (correlation coefficienies 0.9997), obtaining concentration is 13.44ppm, is computed understanding belulinic acid Betulinic acid and dissolves in water Degree increases to 336.00 μ g/mL.

Claims (7)

1. the preparation method of a hydrophilic belulinic acid Betulinic acid preparation, it is characterised in that the method sequentially includes the following steps:
One, weigh 40~60g beta-schardinger dextrin-s to join in 400~500mL distilled water, obtain cyclodextrin solution, take 6~7g NaOH is dissolved in 20~25mL distilled water, obtains NaOH solution, and the NaOH solution of preparation is added dropwise to cyclodextrin In solution, obtain transparent and homogeneous solution, take 7~10g p-methyl benzene sulfonic chlorides and be dissolved in 30~40mL acetonitriles, must mix molten Liquid, is added dropwise to mixed solution in transparent and homogeneous solution, is stirred at room temperature reaction 2~4h, and sucking filtration is precipitated, will Filtrate preserves 12h at 0~5 DEG C, then sucking filtration must precipitate, the precipitation vacuum drying 12~16h obtained twice, obtains white Solid, with absolute ethanol washing white solid 3~5 times, uses dehydrated alcohol 50~80mL every time, obtain 6-tolysulfonyl- Beta-schardinger dextrin-;
Two, weigh 1.5~3g 6-tolysulfonyl-beta-schardinger dextrin-, 20~30mg KI and 0.5~1.0mL diethylenetriamine is molten In the 5~8mL N-Methyl pyrrolidone being dried, under the conditions of 70~80 DEG C, stirring reaction 4~7h, obtains yellow solution, It is cooled to room temperature, yellow solution is poured into 100~150mL dehydrated alcohol separate out white precipitate, collected by suction white precipitate, Wash with 100~150mL dehydrated alcohol and 50~80mL ether respectively, be vacuum dried to obtain 1.3~2.5g product A, by product A dissolves with 8~12mL distilled water, carries out eluting with hydrogen ion exchange resin post, and eluant is followed successively by 400~500mL steamings Distilled water, 400~the ammonia of 500mL 1mol/L, the eluent collecting ammonia part concentrates, is vacuum dried, and obtains product B, Product B is dissolved in 20~30mL distilled water, and decompression, concentrate drying obtains 6-diethylenetriamine chain-beta-schardinger dextrin-;
Three, 2.6~3.9g 6-tolysulfonyl-beta-schardinger dextrin-and 1.2~2.4g 6-diethylenetriamine chains-beta-schardinger dextrin-are weighed, It is dissolved in 80~100mL DMFs, at N2Reaction stirring 2~3 under protection and 75~85 DEG C of condition of water bath heating My god, reaction solution is concentrated into 20~30mL, is then added in 300~400mL acetone produce precipitation, sucking filtration with third Ketone cyclic washing precipitates 3~5 times, then precipitation is dissolved in 10~15mL distilled water and filters with aqueous phase cellulose filter membrane, filter Liquid is dried to obtain diethylenetriamine bridging-beta-schardinger dextrin-dimer;
Four, produce clathrate: weigh 0.7~1.0g diethylenetriamine bridging-beta-schardinger dextrin-dimer in sample cell, add 5~6mL distilled water make it dissolve, and add 30~40mg belulinic acid Betulinic acid, after sonic oscillation 20~60min, on the oscillator Continue vibration 6~7 days, in being placed on high speed centrifuge afterwards, be centrifuged 15~30min with 10000~12000rpm, take supernatant and use Aqueous phase cellulose filter membrane filters, then filtrate is dried, and obtains white powder, is hydrophilic belulinic acid Betulinic acid preparation.
The preparation method of a kind of hydrophilic belulinic acid Betulinic acid preparation the most according to claim 1, it is characterised in that claim in step 2 Take 2g 6-tolysulfonyl-beta-schardinger dextrin-, 25mg KI and 0.57mL diethylenetriamine and be dissolved in the N-methyl that 5mL is dried In ketopyrrolidine.
The preparation method of a kind of hydrophilic belulinic acid Betulinic acid preparation the most according to claim 1 and 2, it is characterised in that step 2 Described resin column specification is: 25 × 450mm, 724 weak-acid cation-exchange resins, and resin packed height is 250mm.
The preparation method of a kind of hydrophilic belulinic acid Betulinic acid preparation the most according to claim 3, it is characterised in that claim in step 3 Take 2.6g 6-tolysulfonyl-beta-schardinger dextrin-and 2.4g 6-diethylenetriamine chain-beta-schardinger dextrin-, be dissolved in 80mL N, N-diformazan In base Methanamide.
The preparation method of a kind of hydrophilic belulinic acid Betulinic acid preparation the most according to claim 4, it is characterised in that claim in step 4 Take 0.8g diethylenetriamine bridging-beta-schardinger dextrin-dimer in sample cell.
The preparation method of a kind of hydrophilic belulinic acid Betulinic acid preparation the most according to claim 5, it is characterised in that add in step 4 Enter 35mg belulinic acid Betulinic acid.
The preparation method of a kind of hydrophilic belulinic acid Betulinic acid preparation the most according to claim 6, it is characterised in that described in step 4 It is dried and uses freeze-drying, particularly as follows: filtrate is placed in freezer dryer, at-50 DEG C of precoolings 6~8h, 30~200 24~36h it are vacuum dried under Pa.
CN201410289470.4A 2014-06-25 2014-06-25 A kind of preparation method of hydrophilic belulinic acid Betulinic acid preparation Expired - Fee Related CN104013972B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410289470.4A CN104013972B (en) 2014-06-25 2014-06-25 A kind of preparation method of hydrophilic belulinic acid Betulinic acid preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410289470.4A CN104013972B (en) 2014-06-25 2014-06-25 A kind of preparation method of hydrophilic belulinic acid Betulinic acid preparation

Publications (2)

Publication Number Publication Date
CN104013972A CN104013972A (en) 2014-09-03
CN104013972B true CN104013972B (en) 2016-12-07

Family

ID=51431150

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410289470.4A Expired - Fee Related CN104013972B (en) 2014-06-25 2014-06-25 A kind of preparation method of hydrophilic belulinic acid Betulinic acid preparation

Country Status (1)

Country Link
CN (1) CN104013972B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104826123B (en) * 2015-04-10 2017-11-10 昆明理工大学 A kind of inclusion compound of oleanolic acid and amine cyclodextrin
CN114225050B (en) * 2022-01-29 2022-12-13 国家卫生健康委科学技术研究所 Preparation and application of ethinylestradiol cyclodextrin compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716491B (en) * 2012-07-02 2013-12-18 昆明理工大学 Clathrate compound of artemisinin series and alkaline cyclodextrin and method for preparing same

Also Published As

Publication number Publication date
CN104013972A (en) 2014-09-03

Similar Documents

Publication Publication Date Title
Dodziuk Molecules with holes–cyclodextrins
CN104013972B (en) A kind of preparation method of hydrophilic belulinic acid Betulinic acid preparation
CN107417752A (en) One kind has compound of active anticancer and its preparation method and application
CN112402620A (en) Nano-medicine with tumor microenvironment reduction responsiveness and preparation method thereof
CN105693676A (en) A method of separating and purifying quercetagetin from tagetes erecta
CN105524127A (en) Gastrodin compound and preparation thereof
CN105541762B (en) Docetaxel-oleic acid prodrug and its nano structured lipid carrier and application
CN103462975A (en) Inclusion compound of mangiferin and alkaline cyclodextrin
CN102233001B (en) Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases as well as preparation method and detection method thereof
CN103665079A (en) Separation and purification method of pachymic acid monomer
CN105997941B (en) Amphiphilic micelle nanocapsule and preparation method and application thereof
Wang et al. A cocrystal for effectively reducing the hepatotoxicity of ethionamide
CN104188980B (en) O-(morpholinyl) ethyl derivative of Cleistanone Cleistanone, preparation method and its usage
Wei et al. Rapid and selective removal of aristolochic acid I in natural products by vinylene-linked iCOF resins
CN106478938B (en) PEG modifier and its preparation of a kind of cucoline and its derivative
CN104162167A (en) Tamibarotene cyclodextrin or cyclodextrin derivative clathrate and preparation method thereof
CN103623345B (en) The preparation method of antivirus oral liquid
CN108530440A (en) A kind of rheum emodin-Halomine pharmaceutical co-crystals and preparation method thereof
CN107320735A (en) A kind of TAM composition and its preparation
CN107412149A (en) Taxol Entogastric lingering molecular engram control Atrigel and preparation method thereof
CN108619163B (en) Polymer micelle containing naringin and preparation method thereof
CN107286210B (en) Acetyl gastrodin compound and preparation method, preparation and application thereof
CN104402964A (en) Cleistanone O-(imidazolyl) ethyl derivative, and preparation method and application thereof
KR20090124597A (en) Preperation method of medicinal ingredients-supramolecular complex
CN111298135B (en) Fraxinellus negundo clathrate compound, pharmaceutical preparation and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20161207

Termination date: 20170625

CF01 Termination of patent right due to non-payment of annual fee